These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12878436)

  • 21. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
    Snow AD; Cummings JA; Lake T
    Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overproduction of perlecan core protein in cultured cells and transgenic mice.
    Hart M; Li L; Tokunaga T; Lindsey JR; Hassell JR; Snow AD; Fukuchi K
    J Pathol; 2001 Jun; 194(2):262-9. PubMed ID: 11400157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.
    Small DH; Williamson T; Reed G; Clarris H; Beyreuther K; Masters CL; Nurcombe V
    Ann N Y Acad Sci; 1996 Jan; 777():316-21. PubMed ID: 8624106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.
    Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G
    Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains.
    Lorente-Gea L; García B; Martín C; Ordiales H; García-Suárez O; Piña-Batista KM; Merayo-Lloves J; Quirós LM; Fernández-Vega I
    J Neuropathol Exp Neurol; 2020 May; 79(5):474-483. PubMed ID: 32232475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.
    Zhang GL; Zhang X; Wang XM; Li JP
    Biomed Res Int; 2014; 2014():516028. PubMed ID: 25157361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
    Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
    J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease.
    Wilhelmus MM; de Waal RM; Verbeek MM
    Mol Neurobiol; 2007 Jun; 35(3):203-16. PubMed ID: 17917109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid binding ligands as Alzheimer's disease therapies.
    Lee VM
    Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.
    Ancsin JB
    Amyloid; 2003 Jun; 10(2):67-79. PubMed ID: 12964414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
    Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G
    Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
    Moss J; Shore I; Woodrow D
    Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
    Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
    Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD; Nochlin D; Sekiguichi R; Carlson SS
    Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
    Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.